Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2024 $ 152,335,000 $ 1 $ 501,435,000   $ (349,101,000)
Beginning balance, Shares at Dec. 31, 2024   50,743,101      
Stock-based compensation 5,161,000   5,161,000    
Net Income (Loss) (35,943,000)       (35,943,000)
Ending balance at Mar. 31, 2025 121,553,000 $ 1,000 506,596,000   (385,044,000)
Ending balance, Shares at Mar. 31, 2025   50,743,101      
Beginning balance at Dec. 31, 2024 152,335,000 $ 1 501,435,000   (349,101,000)
Beginning balance, Shares at Dec. 31, 2024   50,743,101      
Ending balance at Dec. 31, 2025 112,051,000 $ 1,000 628,982,000   (516,957,000)
Ending Balance at Dec. 31, 2025       $ 25,000  
Ending balance, Shares at Dec. 31, 2025   100,479,323      
Stock-based compensation 5,256,000   5,256,000    
Net unrealized losses on available-for-sale securities (25)     (25)  
Issuance of common stock in connection with exercise of stock options 32,000   32,000    
Issuance of common stock in connection with exercise of stock options, Shares   15,113      
Issuance of common stock upon exercise of pre-funded warrants, Shares   2,775,100      
Issuance of common stock, warrants and pre-funded warrants, net of issuance costs, Value 6,938   6,938    
Issuance of common stock from ATM offering   8,055,260      
Issuance of common stock from ATM offering, Amount 22,568,000   22,568,000    
Net Income (Loss) (43,515,000)       (43,515,000)
Ending balance at Mar. 31, 2026 $ 103,305,000 $ 1,000 $ 663,776,000 $ 0 $ (560,472,000)
Ending balance, Shares at Mar. 31, 2026   111,324,796